Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) FCF Margin: 2014-2020

Historic FCF Margin for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Dec 2020 value amounting to 580.11%.

  • Avadel Pharmaceuticals' FCF Margin rose 65517.00% to 580.11% in Q4 2020 from the same period last year, while for Dec 2020 it was -309.71%, marking a year-over-year decrease of 24494.00%. This contributed to the annual value of 433.12% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q4 2020, Avadel Pharmaceuticals' FCF Margin is 580.11%, which was up 84.90% from 313.75% recorded in Q3 2020.
  • In the past 5 years, Avadel Pharmaceuticals' FCF Margin registered a high of 580.11% during Q4 2020, and its lowest value of -129.20% during Q1 2019.
  • For the 3-year period, Avadel Pharmaceuticals' FCF Margin averaged around 9.56%, with its median value being -71.73% (2018).
  • In the last 5 years, Avadel Pharmaceuticals' FCF Margin tumbled by 1,246,553bps in 2016 and then skyrocketed by 65,517bps in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' FCF Margin (Quarterly) stood at 17.50% in 2016, then crashed by 5,742bps to -39.92% in 2017, then slumped by 7,737bps to -117.29% in 2018, then skyrocketed by 4,223bps to -75.06% in 2019, then skyrocketed by 65,517bps to 580.11% in 2020.
  • Its FCF Margin was 580.11% in Q4 2020, compared to 313.75% in Q3 2020 and -77.11% in Q2 2020.